Schedule 13G ownership disclosure

OnKure Therapeutics, Inc.

Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Cantor Fitzgerald Securities

    Shares: 669,539.00 · Class: 5.2%

  • Cantor Fitzgerald & Co.

    Shares: 669,539.00 · Class: 5.2%

  • Cantor Fitzgerald, L.P.

    Shares: 669,539.00 · Class: 5.2%

  • CF Group Management, Inc.

    Shares: 669,539.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-076638
Form type
SCHEDULE 13G
Filer
CANTOR FITZGERALD & CO.
CIK
CIK 17018
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub